These alterations modulate upstream/downstream intracellular cell growth signaling such as MAPK and mammalian target of rapamycin (mTOR), modify the cell cycle checkpoints, inhibit apoptosis, and alter DNA replication, thereby enhancing cancer cell growth. This evidence concerns the gene MTOR and cancer.